BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 28396495)

  • 1. Clonal selection and asymmetric distribution of human leukemia in murine xenografts revealed by cellular barcoding.
    Belderbos ME; Koster T; Ausema B; Jacobs S; Sowdagar S; Zwart E; de Bont E; de Haan G; Bystrykh LV
    Blood; 2017 Jun; 129(24):3210-3220. PubMed ID: 28396495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of chemotherapy-resistant patient-derived acute lymphoblastic leukemia clones in murine xenografts using cellular barcodes.
    Jacobs S; Ausema A; Zwart E; Weersing E; de Haan G; Bystrykh LV; Belderbos ME
    Exp Hematol; 2020 Nov; 91():46-54. PubMed ID: 32946982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variegated clonality and rapid emergence of new molecular lesions in xenografts of acute lymphoblastic leukemia are associated with drug resistance.
    Nowak D; Liem NL; Mossner M; Klaumünzer M; Papa RA; Nowak V; Jann JC; Akagi T; Kawamata N; Okamoto R; Thoennissen NH; Kato M; Sanada M; Hofmann WK; Ogawa S; Marshall GM; Lock RB; Koeffler HP
    Exp Hematol; 2015 Jan; 43(1):32-43.e1-35. PubMed ID: 25450514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Donor-to-Donor Heterogeneity in the Clonal Dynamics of Transplanted Human Cord Blood Stem Cells in Murine Xenografts.
    Belderbos ME; Jacobs S; Koster TK; Ausema A; Weersing E; Zwart E; de Haan G; Bystrykh LV
    Biol Blood Marrow Transplant; 2020 Jan; 26(1):16-25. PubMed ID: 31494231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic clonal progression in xenografts of acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21.
    Sinclair PB; Blair HH; Ryan SL; Buechler L; Cheng J; Clayton J; Hanna R; Hollern S; Hawking Z; Bashton M; Schwab CJ; Jones L; Russell LJ; Marr H; Carey P; Halsey C; Heidenreich O; Moorman AV; Harrison CJ
    Haematologica; 2018 Apr; 103(4):634-644. PubMed ID: 29449437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Good engraftment of B-cell precursor ALL in NOD-SCID mice.
    Baersch G; Möllers T; Hötte A; Dockhorn-Dworniczak B; Rübe C; Ritter J; Jürgens H; Vormoor J
    Klin Padiatr; 1997; 209(4):178-85. PubMed ID: 9293448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring of engraftment and progression of acute lymphoblastic leukemia in individual NOD/SCID mice.
    Nijmeijer BA; Mollevanger P; van Zelderen-Bhola SL; Kluin-Nelemans HC; Willemze R; Falkenburg JH
    Exp Hematol; 2001 Mar; 29(3):322-9. PubMed ID: 11274760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative distribution of patient-derived leukemia clones in murine xenografts revealed by cellular barcodes.
    Jacobs S; Ausema A; Zwart E; Weersing E; Kingma MJ; El Menshawi YAS; de Haan G; Bystrykh LV; Belderbos ME
    Leukemia; 2020 Jun; 34(6):1669-1674. PubMed ID: 31852987
    [No Abstract]   [Full Text] [Related]  

  • 9. Speed of leukemia development and genetic diversity in xenograft models of T cell acute lymphoblastic leukemia.
    Poglio S; Lewandowski D; Calvo J; Caye A; Gros A; Laharanne E; Leblanc T; Landman-Parker J; Baruchel A; Soulier J; Ballerini P; Clappier E; Pflumio F
    Oncotarget; 2016 Jul; 7(27):41599-41611. PubMed ID: 27191650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability of patient-specific features of altered DNA replication timing in xenografts of primary human acute lymphoblastic leukemia.
    Sasaki T; Rivera-Mulia JC; Vera D; Zimmerman J; Das S; Padget M; Nakamichi N; Chang BH; Tyner J; Druker BJ; Weng AP; Civin CI; Eaves CJ; Gilbert DM
    Exp Hematol; 2017 Jul; 51():71-82.e3. PubMed ID: 28433605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Considerations for monitoring minimal residual disease using immunoglobulin clonality in patients with precursor B-cell lymphoblastic leukemia.
    Jo I; Chung NG; Lee S; Kwon A; Kim J; Choi H; Jang W; Kim S; Lee JW; Yoon JH; Cho B; Han K; Kim Y; Kim M
    Clin Chim Acta; 2019 Jan; 488():81-89. PubMed ID: 30389459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD34+CD38+CD19+ as well as CD34+CD38-CD19+ cells are leukemia-initiating cells with self-renewal capacity in human B-precursor ALL.
    Kong Y; Yoshida S; Saito Y; Doi T; Nagatoshi Y; Fukata M; Saito N; Yang SM; Iwamoto C; Okamura J; Liu KY; Huang XJ; Lu DP; Shultz LD; Harada M; Ishikawa F
    Leukemia; 2008 Jun; 22(6):1207-13. PubMed ID: 18418410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Xenografts of highly resistant leukemia recapitulate the clonal composition of the leukemogenic compartment.
    Schmitz M; Breithaupt P; Scheidegger N; Cario G; Bonapace L; Meissner B; Mirkowska P; Tchinda J; Niggli FK; Stanulla M; Schrappe M; Schrauder A; Bornhauser BC; Bourquin JP
    Blood; 2011 Aug; 118(7):1854-64. PubMed ID: 21670474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetically engineered mesenchymal stromal cells produce IL-3 and TPO to further improve human scaffold-based xenograft models.
    Carretta M; de Boer B; Jaques J; Antonelli A; Horton SJ; Yuan H; de Bruijn JD; Groen RWJ; Vellenga E; Schuringa JJ
    Exp Hematol; 2017 Jul; 51():36-46. PubMed ID: 28456746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engraftment of low numbers of pediatric acute lymphoid and myeloid leukemias into NOD/SCID/IL2Rcγnull mice reflects individual leukemogenecity and highly correlates with clinical outcome.
    Woiterski J; Ebinger M; Witte KE; Goecke B; Heininger V; Philippek M; Bonin M; Schrauder A; Röttgers S; Herr W; Lang P; Handgretinger R; Hartwig UF; André MC
    Int J Cancer; 2013 Oct; 133(7):1547-56. PubMed ID: 23526331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonal evolution of immunoglobulin heavy chain rearrangements in childhood B-precursor acute lymphoblastic leukemia after engraftment in SCID mice.
    Steenbergen EJ; Verhagen OJ; Nibbering CP; van den Berg H; van Leeuwen EF; Behrendt H; von dem Borne AE; van der Schoot CE
    Leukemia; 1996 Sep; 10(9):1471-8. PubMed ID: 8751465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential kinetics of engraftment and induction of CD10 on human pre-B leukemia cell lines in immune deficient scid mice.
    Kamel-Reid S; Dick JE; Greaves A; Murdoch B; Doedens M; Grunberger T; Thorner P; Freedman MH; Phillips RA; Letarte M
    Leukemia; 1992 Jan; 6(1):8-17. PubMed ID: 1531243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tracing dynamics and clonal heterogeneity of Cbx7-induced leukemic stem cells by cellular barcoding.
    Klauke K; Broekhuis MJC; Weersing E; Dethmers-Ausema A; Ritsema M; González MV; Zwart E; Bystrykh LV; de Haan G
    Stem Cell Reports; 2015 Jan; 4(1):74-89. PubMed ID: 25434821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spatiotemporal regulation of clonogenicity in colorectal cancer xenografts.
    van der Heijden M; Miedema DM; Waclaw B; Veenstra VL; Lecca MC; Nijman LE; van Dijk E; van Neerven SM; Lodestijn SC; Lenos KJ; de Groot NE; Prasetyanti PR; Arricibita Varea A; Winton DJ; Medema JP; Morrissey E; Ylstra B; Nowak MA; Bijlsma MF; Vermeulen L
    Proc Natl Acad Sci U S A; 2019 Mar; 116(13):6140-6145. PubMed ID: 30850544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The induction of CD10 on a pre-B leukemia cell line occurs with progression of the disease in scid mice.
    Ishii E; Greaves A; Grunberger T; Freedman MH; Letarte M
    Leukemia; 1993 Oct; 7(10):1592-601. PubMed ID: 7692193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.